Patch test study with calcipotriol ointment in different patient groups, including psoriatic patients with and without adverse dermatitis

Acta Dermato-Venereologica

Volumn 76, Issue 3, 1996, Pages 194-202

  Fullerton, A ^a   Avnstorp, C ^b   Agner, T ^c   Dahl, J C ^d   Olsen, L O ^e   Serup, J ^a  

^a Leo Pharmaceutical Products ^*  (Denmark)

^b Dermatology Clinic   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d Dermatological Clinic   (Denmark)

^e BISPEBJERG HOSPITAL   (Denmark)

Author keywords

clinical study; non invasive methods; patient group comparison; ROAT test

Indexed keywords

CALCIPOTRIOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATCH TEST; PRIORITY JOURNAL; PSORIASIS; RANDOMIZED CONTROLLED TRIAL; SKIN BLOOD FLOW; SKIN IRRITATION; TOPICAL DRUG ADMINISTRATION;

ADULT; AGED; CALCITRIOL; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, CONTACT; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PATCH TESTS; PSORIASIS; SKIN; VEHICLES;

EID: 0029976742     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Dubertret L, Wallach D, Souteyrand P, Perussel M, Kalis B, Meynadier J, et al. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. J Am Acad Dermatol 1992; 27: 983-988.
2. Kragballe K, Gjertsen BT, de Hoop D, Karlsmark T, van de Kerkhof PMC, Larkö O, et al. Double-blind, right left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337: 193-196.
3. Ramsay CA, Berth-Jones J, Brundin G, Cunliffe WJ, Dubertret L, van de Kerkhof PMC, et al. Long-term use of topical calcipotriol in chronic plaque psoriasis. Dermatology 1994; 189: 260-264.
4. Cunliffe WJ, Berth-Jones J, Claudy A, Fairiss G, Goldin D, Gratton D, et al. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad Dermatol 1992; 26: 736-743.
5. Berth-Jones J, Chu AC, Dodd WAH, Ganpule M, Griffiths WAD, Haydey RP, et al. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992; 127: 266-271.
6. 3 analogue. Contact Dermatitis 1991; 25: 139.
7. Bruynzeel DP, Hol CW, Nieboer C. Allergic contact dermatitis to calcipotriol. Br J Dermatol 1992; 127: 66.
8. Steinkjer B. Contact dermatitis from calcipotriol. Contact Dermatitis 1994; 31: 122.
9. De Groot AC. Contact allergy to calcipotriol. Contact Dermatitis 1994; 30: 242-243.
10. Adams RM. Patch testing a recapitulation. J Am Acad dermatol 1981; 5: 629-643.
11. Wahlberg JE. Patch testing. In: Rycroft RJG, Menné T, Frosch PJ, Benezra C, eds. Textbook of contact dermatitis. Berlin: Springer-Verlag, 1992: 241-268.
12. Hannuksela M, Salo H. The repeated open application test (ROAT). Contact Dermatitis 1986; 14: 221-227.
13. Serup J, Jemec GBE, eds. Handbook of non-invasive methods and the skin. Boca Raton: CRC Press, Inc. 1995.
14. Pathak MA, Fitzpatrick TB. Preventive treatment of sunburn, dermatoheliosis, and skin cancer with sun-protective agents. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine, Vol. 1. New York: McGraw-Hill Inc, 1993: 1689-1717.
15. Hayakawa R, Suzuki M, Fujimoto Y. Results of a dermal safety study of MC 903 ointment incorporated with an active vitamin D analogue. Skin Res 1993; 35: 109-116.
16. Agner T, Serup J. Skin reactions to irritants assessed by non-invasive bioengineering methods. Contact Dermatitis 1989; 20: 352-359.